Keyphrases
High-risk Population
100%
Homozygous Familial Hypercholesterolemia (HoFH)
100%
Clinical Trials
25%
Novel Therapies
25%
Statins
12%
Cardiovascular Outcomes
12%
Low-density Lipoprotein Cholesterol (LDL-C)
12%
Novel Treatments
12%
Low-density Lipoprotein Cholesterol Level
12%
Atherosclerotic Cardiovascular Disease Risk
12%
Lipid-lowering Therapy
12%
Receptor Activity
12%
Multiple Classes
12%
Low-density Lipoprotein
12%
Ezetimibe
12%
Low-density Lipoprotein Receptor
12%
Number of Individuals
12%
Surrogate Measures
12%
Cholesterol-lowering Therapy
12%
PCSK9 Inhibitors
12%
Medicine and Dentistry
High Risk Population
100%
Familial Hypercholesterolemia
100%
Clinical Trial
25%
Low Density Lipoprotein Cholesterol
25%
Cardiovascular System
12%
Atherosclerosis
12%
Study Participant
12%
Statin
12%
Low-Density Lipoprotein
12%
Ezetimibe
12%
LDL Receptor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Familial Hypercholesterolemia
100%
Clinical Trial
25%
Low Density Lipoprotein Cholesterol
25%
Atherosclerosis
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Low Density Lipoprotein Receptor
12%
Coronary Artery Atherosclerosis
12%
Ezetimibe
12%
Low Density Lipoprotein
12%